Related Experiment Videos
Indomethacin and gentamycin treatment in experimental kidney infection
Abstract:
Experiences in experimental renal infection of rats treated with gentamycin, indomethacin, and by the combination of both drugs are reported. Urine osmolality of animals treated with combined therapy normalized after the first dose of indomethacin; their antibody titers against the pathogenic bacteria, as compared to the controls, decreased significantly. When drugs were administered separately the above immunologic changes could not be observed. Indomethacin did not inhibit the antibacterial effect of gentamycin and, administered alone, it increased the renal concentration ability.
Insights
Combined gentamycin and indomethacin therapy normalized urine osmolality and reduced antibody titers in experimental renal infections. Separate drug administration did not yield these significant immunologic changes.
Area of Science:
- Nephrology
- Pharmacology
- Immunology
Background:
- Experimental renal infections are a significant challenge in veterinary and human medicine.
- Understanding drug interactions is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate the effects of combined gentamycin and indomethacin therapy on experimental renal infections in rats.
- To evaluate the impact of this combination on urine osmolality and antibody titers.
Main Methods:
- Rats with experimental renal infections were treated with gentamycin, indomethacin, or a combination of both.
- Urine osmolality and antibody titers against pathogenic bacteria were measured and compared to control groups.
Main Results:
- Combined therapy significantly normalized urine osmolality after the first indomethacin dose.
- Antibody titers decreased significantly in the combination therapy group compared to controls.
- Separate drug administration did not produce these immunologic effects.
- Indomethacin did not impede gentamycin's antibacterial action and enhanced renal concentration ability when used alone.
Conclusions:
- Combined gentamycin and indomethacin therapy demonstrates a synergistic effect in managing experimental renal infections.
- This combination therapy offers potential benefits by modulating the immune response and improving renal function.